Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

First, you spend a small fortune just to buy the unit and install it. Then comes the real nightmare: maintenance and repairs that are outrageously expensive, to the point where it feels like a scam.

Recently, Environmental Protection Agency Administrator Lee Zeldin announced the end of federal credits for automakers that install start/stop systems, part of a broader overhaul of greenhouse gas ...